Meeting Report of the XIV International Small Bowel Transplant Symposium: Summary of Presentations,Workshops,and Debates From a Comprehensive Meeting on Intestinal Failure,Rehabilitation,and Transplantation,Buenos Aires,Argentina,June 10–13,2015
Restricted accessReview articleFirst published online 2017
Meeting Report of the XIV International Small Bowel Transplant Symposium: Summary of Presentations,Workshops,and Debates From a Comprehensive Meeting on Intestinal Failure,Rehabilitation,and Transplantation,Buenos Aires,Argentina,June 10–13,2015
The 2015 meeting of the Intestinal Transplant Association was held in Buenos Aires, Argentina. This was the 14th International Small Bowel Transplant Symposium, and it was the first meeting organized as a joint venture of the Transplantation Society, the Intestinal Transplant Association, and the Argentinean Transplant Society (Sociedad Argentina de Trasplantes). Innovative aspects of the classic meeting format included workshops sessions, debates, and multicenter studies. This report highlights the most prominent scientific contributions and results of the first such symposium in a Latin American country.
SmithJMSkeansMAHorslenSP. OPTN/SRTR 2013 annual data report: intestine. Am J Transplant. 2015;15(suppl 2):1-16.
2.
PironiLGuidettiMVerrastroO. Lipidomics profile of red blood cell membrane in patients on long-term home parenteral nutrition: effect of two different lipid emulsions [abstract 120]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S1.
3.
CalkinsHDunnJShewS. The evolution of plasma phytosterols and cytokines and erythrocyte polyunsaturated fatty acids in children with intestinal failure associated liver disease who received six months of intravenous fish oil [abstract 145]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S11
4.
NaderELambeCTalbotecC. Long-term outcome of children receiving home parenteral nutrition: a 14-year single-center experience in 251 patients [abstract 121]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S1.
5.
RajanayagamJBeathSGowenH. 24-year outcomes of pediatric intestinal failure associated liver disease—experience of a transplant centre [abstract 658]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S109.
6.
EchevarríaCSolarHCabanneADíazCCrivelliAGondolesiG. Parenteral nutrition associated liver disease: searching for “the lost indicator” [abstract 140]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S8.
7.
RumboCMartínezMCabanneATrentadueJFernandezAGondolesiG. Utility of APRI to predict liver fibrosis in intestinal failure associated liver disease in pediatric patients [abstract 657]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S108.
8.
CrivelliASolarHMorandoL. Cost-analysis of home vs hospital-based parenteral nutrition in intestinal failure patiens [abstract 144]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S11.
9.
KosarCSteinbergKDe SilvaNAvitzurYWalesP. Outpatient cost for pediatric intestinal failure patients for the first year after primary discharge [abstract 143]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S10.
10.
AlomariAI. The use of the internal thoracic vein for percutaneous central venous access in an infant. J Vasc Interv Radiol. 2010;21(3):400-402.
11.
ChopraVAnandSHicknerA. Risk of venous thoromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet. 2013;382:311-325.
12.
GoltzJPSchmidJSRitterCO. Identification of risk factors for catheter-related thrombosis in patients with totally implantable venous access ports in the forearm. J Vasc Access. 2012;13(1):79-85.
13.
GeertsW. Central venous catheter–related thrombosis. Hematology Am Soc Hematol Educ Program. 2014;2014(1):306-311.
14.
KangJRLiHLChenWJ. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors: comment. Thromb Haemost. 2014;12(11):1943-1944.
15.
JeppesenPFujiokaKYoussefNO’KeefeS. Long-term efficacy and safety of teduglutide treatment for patients with intestinal failure associated with short bowel syndrome: final results from STEPS-2, a 24-month, multicenter, open-label, phase III extension study [abstract 122]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S2.
16.
JeppesenPBoullataJZieglerT. Characteristics of patients with intestinal failure associated with short bowel syndrome who achieved independence from parenteral support during treatment with teduglutide [abstract 123]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S2.
17.
FujiokaKSchneiderSLiBYoussefNPapeUJeejeebhoyK. Teduglutide, a recombinant analog of GLP-2, reduces parenteral support in patients with short bowel syndrome regardless of ultra-short remnant bowel and/or no colon-in- continuity anatomy [abstract 190]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S27.
18.
SolarHCrivelliAConstanzaE. Autologous gastro-intestinal reconstruction in adult patients with severe intestinal failure, report of long term outcomes and its correlation with anatomical predicting factors: report from a single center [abstract 655]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S107.
19.
LauroAZanfiCCauteroN. Surgical therapy of post-operative entero-cutaneous fistulas: is resection with primary anastomosis a safe option to avoid early recurrence? Report on 20 cases rescued by Bologna Center [abstract 424]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S65.
20.
FujikiMHashimotoKKhannaAQuintiniCAbu-ElmagdK. The evolving concept of autologous gut reconstruction in the recent era of visceral transplantation [abstract 487]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S89.
21.
JainGChallaACookG. Surgical management of short bowel syndrome after bariatric surgery [abstract 421]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S63.
22.
Abu El-MagdKKhannaACostaG. Current management of gut failure after gastric bypass: autologous reconstruction and visceral transplantation [abstract 422]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S64.
23.
TorresCMohanPSehgalSKhanMBadalyanVSandlerA. Outcome of the First 100 pediatric patients with short bowel syndrome treated in the intestinal rehabilitation program at children’s national health system—Washington, DC [abstract 142]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S10.
24.
ZanfiCAugustoLOdaldiF. Surgical intestinal rehabilitation program in adult patients with intestinal failure [abstract 428]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S67.
25.
JesterIGeeOProtheroeS. Multi-disciplinary overview of children with complex intestinal failure [abstract 149]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S13.
26.
GupteGBeathSKellyDMillarABoothI. Current issues in the management of intestinal failure. Arch Dis Child. 2006;91:259-264.
27.
BianchiA. Experience with longitudinal intestinal lengthening and tailoring. Eur J Pediatr Surg. 1999;9:256-259.
28.
JavidPJSanchezSEHorslenSPHealeyPJ. Intestinal lengthening and nutritional outcomes in children with short bowel syndrome. Am J Surg. 2013;205(5):576-578.
29.
CserniTVargaGErcesD. Spiral intestinal lengthening and tailoring—first in vivo study. J Pediatr Surg. 2013;48(9):1907-1913.
30.
SudanDThompsonJBothaJ. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg. 2007;246(4):593-601.
31.
FrongiaGKesslerMWeihSNickkholghAMehrabiAHolland-CunzS. Comparison of LILT and STEP procedures in children with short bowel syndrome—a systematic review of the literature. J Pediatr Surg. 2013;48(8):1794-1805.
32.
FezaaHPoissonCLicoisM. Coordination nurses in children with intestinal failure or transplantation in paris: role and networking [abstract 186]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S25.
33.
MatsumotoCHawksworthJKozlowskiS. Incidence and timing of de novo donor specific antibody in intestinal transplantation [abstract 155]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S15.
34.
ChengEWozniakLVenickR. Removal of donor-specific antibodies after intestinal transplantation [abstract 131]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S5.
35.
HawksworthJRosen-BronsonSGirlandaR. Preformed donor specific antibody in liver exclusion intestine transplants: 3-year outcomes [abstract 133]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S6.
36.
CeulemansLBrazaFMonbaliuD. Immunomodulatory intestinal transplant protocol improves long-term patient and graft survival by promotion of CD4+ CD45RA- FoxP3high T-regulatory cells [abstract 366]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S46.
37.
GirlandaRDesaiCKhanK. Sirolimus in intestinal transplantation: single center experience [abstract 132]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S5.
38.
BeduschiTGarciaJSelvaggiG. Multivisceral transplant without an ostomy—initial experience in 15 patients [abstract 724]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S127.
HibiTShinodaMHoshinoK. Outcomes of living donors in small bowel transplantation [abstract 513]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S100.
41.
WuGZhaoQWangWShiHWangMLiM. Living-related intestinal transplantation: a single center experience [abstract 708]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S120.
42.
RamischDRumboCEchevarriaC. Isolated long-term outcomes after intestinal transplantation from a single South American Center, lessons learned [abstract 710]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S121.
43.
EkserBNagaiSKubalCFridellJTectorJMangusR. Intestine and multivisceral re-transplantation: indications and survival [abstract 721]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S125.
44.
CalvoJJimenezCGarcia-SesmaA. Small bowel transplantation in adults: results after 10 years of experience in Spain. What have we learned? [abstract 716]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S124.
45.
BarlowAAminISharkeyL. Single-centre outcomes of adult multivisceral and intestinal re-transplantation [abstract 714]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S123.
46.
RutterCSharkeyLChukualimB. Outcomes following intestinal and multivisceral transplantation at Addenbrooke’s Hospital, Cambridge, UK [abstract 711]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S121.
47.
FarmerDChengEWozniakL. Outcomes after intestinal transplantation: results from a large single center review [abstract 697]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S116.
48.
GerlachUFrank PapeUJoerresD. 15 years of intestinal and multivisceral transplantation—a single centre experience [abstract 695]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S115.
49.
MatsumotoCHawksworthJKozlowskiS. Single center experience in intestinal transplantation [abstract 696]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S115.
50.
VenickRWozniakLMarcusE. Pediatric intestinal transplant recipients a decade of more later: a detailed nutrition, developmental and psychosocial report [abstract 722]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S126.
51.
NorsaLGupteGBoludaE. Ten years after a successful intestinal transplantation: what is their life? [abstract 365]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S46.
52.
Abu-ElmagdKCostaGBondG. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg. 2009;250:567-581.
53.
SwansonBTalmonGWisecarverJGrantWRadioS. Histologic analysis of chronic rejection in small bowel transplantation: mucosal and vascular alterations. Transplantation. 2013;95:378-382.
54.
BergerMZeeviAFarmerDGAbu-ElmagdKM. Immunologic challenges in small bowel transplantation. Am J Transplant. 2012;12(suppl 4):S2-S8.
55.
StringaPLausadaNGambaroS. Heterotopic small bowel transplantation model in rats: Sprague Dawley to Wistar, a novel donor-recipient combination to study the acute cellular rejection Process [abstract 412]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S60.
56.
BodammerPWitteMBannertK. NOD2-deficiency worsens the clinical outcome in a murine model of short bowel syndrome [abstract 405]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S56.
57.
KroemerADiazJWantaS. Th17-mediated alloimmune responses play a key role in intestinal allograft rejection in humans [abstract 369]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S48.
58.
Pucci MolinerisMRumboCFuxmanC. Analysis of innate lymphoid cells during the follow-up of intestinal transplant patients: a preliminary study [abstract 390]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S52
59.
TrentadueGMensinkPKruseC. Luminal oxygen delivery improves small intestinal ischemic damage in a pig model [abstract 385]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S49.
60.
CeulemansLVerbekeLDecuypereJ. Protective role of farnesoid-X receptor (FXR) agonist in intestinal ischemia reperfusion injury [abstract 386]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S49-S50.
61.
LiYYaoDWangJMaoQGuoMLiJ. Normothermic extracorporeal membrane oxygenation support: improves donor intestinal graft function after cardiac death [abstract 388]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S51.
62.
BarlowAHamedMKhoslaSSagarAGribbleFMurphyM. An experimental model for ex vivo normothermic perfusion of isolated porcine small bowel segments [abstract 389]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S49.
63.
SharkeyLBurlingKRutterCMiddletonSButlerAWoodwardJ. Cytokeratin fragments as a biomarker for intestinal allograft rejection [abstract 409]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S58.
MontagnaniMGuidettiMAgostiniF. Fibroblast growth factor 19 (FGF19) in patients with short bowel syndrome (SBS) on long-term home parenteral nutrition (HPN) [abstract 656]. ISBTS 2015 Transplantation. 2015;99(suppl 1):S108.
66.
Abu-ElmagdKWuGCostaG. Preformed and de novo donor specific antibodies in visceral transplantation: long term outcomes with special reference to the liver. Am J Transpl. 2012;12:3047-3060.
67.
Calp-InalSAjaimyMMelamedML. The prevalence and clinical significance of C1q-binding donor-specific anti-HLA antibodies early and late after kidney transplantation. Kidney Int. 2016;89(1):209-216.
68.
TranAFixlerDHuangRMezaTLacelleCDasBB. Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation. J Am Soc Nephrol. 2016;27(1):293-304.
69.
LefaucheurCVigliettiDBentlejewskiC. IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury. J Am Soc Nephrol. 2016;27(1):293-304.
70.
ChengEKanekuHFarmerD. The role of donor-specific antibodies in intestinal transplantation: experience at the University of California Los Angeles and literature review. Clin Transpl. 2014;153-159.
